116 related articles for article (PubMed ID: 1592528)
1. Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer.
Kaklamanis L; Gatter KC; Hill AB; Mortensen N; Harris AL; Krausa P; McMichael A; Bodmer JG; Bodmer WF
Int J Cancer; 1992 May; 51(3):379-85. PubMed ID: 1592528
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
Momburg F; Ziegler A; Harpprecht J; Möller P; Moldenhauer G; Hämmerling GJ
J Immunol; 1989 Jan; 142(1):352-8. PubMed ID: 2462591
[TBL] [Abstract][Full Text] [Related]
3. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
Smith ME; Marsh SG; Bodmer JG; Gelsthorpe K; Bodmer WF
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5557-61. PubMed ID: 2473473
[TBL] [Abstract][Full Text] [Related]
4. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
[TBL] [Abstract][Full Text] [Related]
5. Serological analysis of the dissociation process of HLA-B and C class I molecules.
Gillet AC; Pérarnau B; Mercier P; Lemonnier FA
Eur J Immunol; 1990 Apr; 20(4):759-64. PubMed ID: 2189736
[TBL] [Abstract][Full Text] [Related]
6. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
7. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
9. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
[TBL] [Abstract][Full Text] [Related]
10. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
13. Cellular localization of blood group antigens (including HLA markers) in human bladder urothelium.
Gane P; Ruttyn Y; Rouger P; Vallancien G; Salmon C
Tissue Antigens; 1988 Aug; 32(2):57-70. PubMed ID: 3057680
[TBL] [Abstract][Full Text] [Related]
14. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
[TBL] [Abstract][Full Text] [Related]
15. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail.
Little AM; Nössner E; Parham P
J Immunol; 1995 May; 154(10):5205-15. PubMed ID: 7537301
[TBL] [Abstract][Full Text] [Related]
17. HLA-C heavy chains free of beta2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-gamma responsiveness.
Giacomini P; Beretta A; Nicotra MR; Ciccarelli G; Martayan A; Cerboni C; Lopalco L; Bini D; Delfino L; Ferrara GB; Siccardi AG; Natali PG
Tissue Antigens; 1997 Dec; 50(6):555-66. PubMed ID: 9458108
[TBL] [Abstract][Full Text] [Related]
18. Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
Cabrera T; Concha A; Ruiz-Cabello F; Garrido F
Scand J Immunol; 1991 Aug; 34(2):147-52. PubMed ID: 1866599
[TBL] [Abstract][Full Text] [Related]
19. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.
Doxiadis I; Westhoff U; Grosse-Wilde H
Blut; 1989 Nov; 59(5):449-54. PubMed ID: 2684299
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.
Ottesen SS; Ahrenkiel V; Kieler J
Cancer Immunol Immunother; 1990; 31(2):93-8. PubMed ID: 2108803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
